﻿{"id":29003,"date":"2025-11-10T10:42:16","date_gmt":"2025-11-10T03:42:16","guid":{"rendered":"https:\/\/nhathuocngocanh.com\/bp\/?p=29003"},"modified":"2025-11-10T10:42:16","modified_gmt":"2025-11-10T03:42:16","slug":"proguanil-hydrochloride","status":"publish","type":"post","link":"https:\/\/nhathuocngocanh.com\/bp\/proguanil-hydrochloride\/","title":{"rendered":"Proguanil Hydrochloride"},"content":{"rendered":"<p><em>(Ph. Eur. monograph 2002)<\/em><\/p>\n<p>C<sub>11<\/sub>H<sub>17<\/sub>Cl<sub>2<\/sub>N<sub>5<\/sub> 290.2 637-32-1<\/p>\n<p><strong>Action and use<\/strong><\/p>\n<p>Antiprotozoal (malaria).<\/p>\n<p><strong>Preparation<\/strong><\/p>\n<p>Proguanil Tablets<\/p>\n<h2>DEFINITION<\/h2>\n<p>N<sup>1<\/sup> -(4-Chlorophenyl)-N<sup>3<\/sup> -(propan-2-yl)imidodicarbonimidic diamide hydrochloride.<\/p>\n<h3>Content<\/h3>\n<p>98.5 per cent to 101.0 per cent (dried substance).<\/p>\n<h2>CHARACTERS<\/h2>\n<h3>Appearance<\/h3>\n<p>White or almost white, crystalline powder.<\/p>\n<h3>Solubility<\/h3>\n<p>Slightly soluble in water, sparingly soluble in anhydrous ethanol, practically insoluble in methylene chloride.<\/p>\n<h2>IDENTIFICATION<\/h2>\n<p>First identification: A, C.<\/p>\n<p>Second identification: B, C.<\/p>\n<p>A. Infrared absorption spectrophotometry (2.2.24).<\/p>\n<p>Comparison: proguanil hydrochloride CRS.<\/p>\n<p>B. Dissolve 0.4 g in 50 mL of water R (solution A). To 15 mL of solution A add 2 mL of dilute sodium hydroxide solution R. Extract with 20 mL of ethyl acetate R. Wash the organic layer with water R, evaporate to dryness and dry at 105 \u00b0C. The melting point (2.2.14) of the residue is 130 \u00b0C to 133 \u00b0C.<\/p>\n<p>C. It gives reaction (a) of chlorides (2.3.1).<\/p>\n<h2>TESTS<\/h2>\n<h3>Acidity or alkalinity<\/h3>\n<p>To 35 mL of water R maintained at 60-65 \u00b0C, add 0.2 mL of methyl red mixed solution R. Neutralise to a grey colour with either 0.01 M sodium hydroxide or 0.01 M hydrochloric acid. Add 0.4 g of the substance to be examined and stir until completely dissolved. The solution is grey or green. Not more than 0.2 mL of 0.01 M hydrochloric acid is required to change the colour of the solution to reddish-violet.<\/p>\n<h3>Related substances<\/h3>\n<p>Liquid chromatography (2.2.29).<\/p>\n<p>Solvent mixture acetonitrile R, methanol R, water R (20:20:60 V\/V\/V).<\/p>\n<p>Test solution (a): Dissolve 20 mg of the substance to be examined in the solvent mixture and dilute to 100.0 mL with the solvent mixture.<\/p>\n<p>Test solution (b): Dissolve 20 mg of the substance to be examined in the solvent mixture and dilute to 50.0 mL with the solvent mixture.<\/p>\n<p>Reference solution (a): Dissolve 5 mg of proguanil for system suitability CRS (containing impurity G) in the solvent mixture and dilute to 25.0 mL with the solvent mixture.<\/p>\n<p>Reference solution (b): Dilute 1.0 mL of test solution (a) to 100.0 mL with the solvent mixture. Dilute 1.0 mL of this solution to 10.0 mL with the solvent mixture.<\/p>\n<p>Reference solution (c): Dissolve 4.0 mg of proguanil impurity B CRS in the solvent mixture and dilute to 100.0 mL with the solvent mixture. Dilute 1.0 mL of the solution to 50.0 mL with the solvent mixture. Dilute 1.0 mL of this solution to 10.0 mL with the solvent mixture.<\/p>\n<p>Column:<\/p>\n<p>\u2014 size: l = 0.075 m, \u00d8 = 4.6 mm;<\/p>\n<p>\u2014 stationary phase: octylsilyl silica gel for chromatography R (3.5 \u03bcm);<\/p>\n<p>\u2014 temperature: 40 \u00b0C.<\/p>\n<p>Mobile phase:<\/p>\n<p>\u2014 mobile phase A: dissolve 0.65 g of sodium pentanesulfonate R and 7.0 g of sodium perchlorate R in water for chromatography R and dilute to 1000 mL with the same solvent; adjust to pH 3.0 with a 1 per cent V\/V solution of trifluoroacetic acid R;<\/p>\n<p>\u2014 mobile phase B: dissolve 0.65 g of sodium pentanesulfonate R and 7.0 g of sodium perchlorate R in a mixture of 20 volumes of water for chromatography R, 40 volumes of acetonitrile for chromatography R and 40 volumes of methanol R1 and dilute to 1000 mL with the same solvent mixture; add 4 mL of a 1 per cent V\/V solution of trifluoroacetic acid R;<\/p>\n<table style=\"border-collapse: collapse; width: 100%; height: 85px;\">\n<tbody>\n<tr style=\"height: 43px;\">\n<td style=\"width: 33.3333%; height: 43px; text-align: center;\"><strong>Time<\/strong><br \/>\n<strong>(min)<\/strong><\/td>\n<td style=\"width: 33.3333%; height: 43px; text-align: center;\"><strong>Mobile phase A<\/strong><br \/>\n<strong>(per cent V\/V)<\/strong><\/td>\n<td style=\"width: 33.3333%; height: 43px; text-align: center;\"><strong>Mobile phase B<\/strong><br \/>\n<strong>(per cent V\/V)<\/strong><\/td>\n<\/tr>\n<tr style=\"height: 21px;\">\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">0 &#8211; 3<\/td>\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">75<\/td>\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">25<\/td>\n<\/tr>\n<tr style=\"height: 21px;\">\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">3 &#8211; 23<\/td>\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">75 \u2192 40<\/td>\n<td style=\"width: 33.3333%; height: 21px; text-align: center;\">25 \u2192 60<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Flow rate: 1.5 mL\/min.<\/p>\n<p>Detection: Spectrophotometer at 235 nm.<\/p>\n<p>Injection: 20 \u03bcL of test solution (a) and reference solutions (a) and (b).<\/p>\n<p>Identification of impurities: Use the chromatogram supplied with proguanil for system suitability CRS and the chromatogram obtained with reference solution (a) to identify the peak due to impurity G.<\/p>\n<p>Relative retention: With reference to proguanil (retention time = about 16 min): impurity G = about 1.05.<\/p>\n<p>System suitability Reference solution (a):<\/p>\n<p>\u2014 peak-to-valley ratio: minimum 5.0, where H<sub>p<\/sub> = height above the baseline of the peak due to impurity G and H<sub>v<\/sub> = height above the baseline of the lowest point of the curve separating this peak from the peak due to proguanil.<\/p>\n<p>Calculation of percentage contents:<\/p>\n<p>\u2014 for each impurity, use the concentration of proguanil hydrochloride in reference solution (b).<\/p>\n<p>Limits:<\/p>\n<p>\u2014 unspecified impurities: for each impurity, maximum 0.10 per cent;<\/p>\n<p>\u2014 total: maximum 0.2 per cent;<\/p>\n<p>\u2014 reporting threshold: 0.05 per cent, except for impurity B.<\/p>\n<h3>Impurity B<\/h3>\n<p>Liquid chromatography (2.2.29) as described in the test for related substances with the following modifications.<\/p>\n<p>Injection: Test solution (b) and reference solution (c).<\/p>\n<p>Identification of impurities Use the chromatogram obtained with reference solution (c) to identify the peak due to impurity B.<\/p>\n<p>Relative retention: With reference to proguanil (retention time = about 16 min): impurity B = about 0.2.<\/p>\n<p>System suitability: Reference solution (c):<\/p>\n<p>\u2014 signal-to-noise ratio: minimum 10 for the peak due to impurity B.<\/p>\n<p>Limit:<\/p>\n<p>\u2014 impurity B: not more than the area of the corresponding peak in the chromatogram obtained with reference solution (c) (200 ppm).<\/p>\n<h3>Loss on drying (2.2.32)<\/h3>\n<p>Maximum 0.5 per cent, determined on 1.000 g by drying in an oven at 105 \u00b0C.<\/p>\n<h3>Sulfated ash (2.4.14)<\/h3>\n<p>Maximum 0.1 per cent, determined on 1.0 g.<\/p>\n<h2>ASSAY<\/h2>\n<p>Suspend 0.100 g in 20 mL of anhydrous acetic acid R, shake and heat at 50 \u00b0C for 5 min. Cool to room temperature and add 40 mL of acetic anhydride R. Titrate with 0.1 M perchloric acid, determining the end-point potentiometrically (2.2.20).<\/p>\n<p>1 mL of 0.1 M perchloric acid is equivalent to 14.51 mg of C<sub>11<\/sub>H<sub>17<\/sub>Cl<sub>2<\/sub>N<sub>5<\/sub>.<\/p>\n<h2>STORAGE<\/h2>\n<p>Protected from light.<\/p>\n<h2>IMPURITIES<\/h2>\n<p>Specified impurities B.<\/p>\n<p>Other detectable impurities (the following substances would, if present at a sufficient level, be detected by one or other of the tests in the monograph. They are limited by the general acceptance criterion for other\/unspecified impurities and\/or by the general monograph Substances for pharmaceutical use (2034). It is therefore not necessary to identify these impurities for demonstration of compliance. See also 5.10. Control of impurities in substances for pharmaceutical use) A, C, D, E, F, G.<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29005\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/2-47-300x163.jpg\" alt=\"Proguanil Hydrochloride\" width=\"300\" height=\"163\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/2-47-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/2-47-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/2-47-768x416.jpg 768w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/2-47.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>A. N-cyano-N\u2032-(propan-2-yl)guanidine,<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29006\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/3-46-300x163.jpg\" alt=\"Proguanil Hydrochloride\" width=\"300\" height=\"163\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/3-46-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/3-46-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/3-46-768x416.jpg 768w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/3-46.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>B. 4-chloroaniline,<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29007\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/4-44-300x163.jpg\" alt=\"Proguanil Hydrochloride\" width=\"300\" height=\"163\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/4-44-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/4-44-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/4-44-768x416.jpg 768w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/4-44.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>C. N<sup>1<\/sup> ,N<sup>3<\/sup> -bis(4-chlorophenyl)imidodicarbonimidic diamide,<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29008\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/5-43-300x163.jpg\" alt=\"Proguanil Hydrochloride\" width=\"300\" height=\"163\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/5-43-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/5-43-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/5-43-768x416.jpg 768w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/5-43.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>D. N<sup>1<\/sup> ,N<sup>3<\/sup> -bis(propan-2-yl)imidodicarbonimidic diamide,<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29009\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/6-35-300x163.jpg\" alt=\"Proguanil Hydrochloride\" width=\"300\" height=\"163\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/6-35-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/6-35-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/6-35-768x416.jpg 768w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/6-35.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>E. N-(4-chlorophenyl)-N\u2032-cyanoguanidine,<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29010\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/7-32-300x163.jpg\" alt=\"Proguanil Hydrochloride\" width=\"300\" height=\"163\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/7-32-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/7-32-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/7-32-768x416.jpg 768w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/7-32.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>F. N<sup>1<\/sup> -(3,4-dichlorophenyl)-N<sup>3<\/sup> -(propan-2-yl)imidodicarbonimidic diamide,<\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-29011\" src=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/8-25-300x163.jpg\" alt=\"Proguanil Hydrochloride\" width=\"300\" height=\"163\" srcset=\"https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/8-25-300x163.jpg 300w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/8-25-1024x555.jpg 1024w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/8-25-768x416.jpg 768w, https:\/\/nhathuocngocanh.com\/bp\/wp-content\/uploads\/2025\/11\/8-25.jpg 1200w\" sizes=\"auto, (max-width: 300px) 100vw, 300px\" \/><\/p>\n<p>G. N<sup>1<\/sup> -(3-chlorophenyl)-N<sup>3<\/sup> -(propan-2-yl)imidodicarbonimidic diamide.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>(Ph. Eur. monograph 2002) C11H17Cl2N5 290.2 637-32-1 Action and use Antiprotozoal (malaria). Preparation Proguanil Tablets DEFINITION N1 -(4-Chlorophenyl)-N3 -(propan-2-yl)imidodicarbonimidic diamide hydrochloride. Content 98.5 per cent to 101.0 per cent (dried substance). CHARACTERS Appearance White or almost white, crystalline powder. Solubility Slightly soluble in water, sparingly soluble in anhydrous ethanol, practically insoluble in methylene chloride. IDENTIFICATION&#8230;<\/p>\n","protected":false},"author":4,"featured_media":29004,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[174],"tags":[],"class_list":["post-29003","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-medicinal-substances"],"acf":[],"_links":{"self":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/29003","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/comments?post=29003"}],"version-history":[{"count":2,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/29003\/revisions"}],"predecessor-version":[{"id":29014,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/posts\/29003\/revisions\/29014"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media\/29004"}],"wp:attachment":[{"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/media?parent=29003"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/categories?post=29003"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nhathuocngocanh.com\/bp\/wp-json\/wp\/v2\/tags?post=29003"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}